MINI FUTURE LONG - PFIZER INC | Real-time Bid/Ask 08:56:43 2024-06-27 EDT | ||
| 0.45 EUR / 0.46 EUR | +1.11% |
|
| Current month | -18.18% | ||
| 1 month | -22.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 0.46 | +2.22% |
| 24-06-26 | 0.45 | -10.00% |
| 24-06-25 | 0.5 | -5.66% |
| 24-06-24 | 0.53 | +12.77% |
| 24-06-21 | 0.47 | -2.08% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 04:48 am
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | Morgan Stanley |
| WKN | MD7FPC |
| ISIN | DE000MD7FPC8 |
| Date issued | 2022-08-26 |
| Strike | 22.65 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.15 € |
|---|---|
| Lowest since issue | 0.25 € |
| Spread | 0.01 € |
| Spread % | 2.17% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.42
USD
Average target price
31.92
USD
Spread / Average Target
+16.39%
- Stock Market
- Certificates
- Certificat
